tiprankstipranks
Primo Nutraceuticals (BUGVF)
OTHER OTC:BUGVF
US Market

Primo Nutraceuticals (BUGVF) Financial Statements

Compare
8 Followers

Primo Nutraceuticals Financial Overview

Primo Nutraceuticals's market cap is currently $26.00. The company's EPS TTM is $; its P/E ratio is ―; Primo Nutraceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 19
Income Statement
Total RevenueC$ 0.00
Gross ProfitC$ 0.00
Operating IncomeC$ -1.19M
EBITDAC$ -1.19M
Net IncomeC$ -3.87M
Balance Sheet
Cash & Short-Term InvestmentsC$ 40.59K
Total AssetsC$ 2.48M
Total DebtC$ 596.60K
Net DebtC$ 595.45K
Total LiabilitiesC$ 3.03M
Stockholders' EquityC$ -543.82K
Cash Flow
Free Cash FlowC$ -1.36M
Operating Cash FlowC$ -1.10M
Investing Cash FlowC$ -779.66K
Financing Cash FlowC$ 1.88M
Currency in CAD

Primo Nutraceuticals Earnings and Revenue History

Primo Nutraceuticals Debt to Assets

Primo Nutraceuticals Cash Flow

Primo Nutraceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis